These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2496541)

  • 21. [Immunoenzyme analysis method for detecting anti-Pseudomonas aeruginosa antibodies in persons inoculated with pyoimmunogen].
    Severtsova MK; Vaĭda MB; Varró R
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jan; (1):55-9. PubMed ID: 3920846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
    Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of a study of the safety, reactogenicity and immunologic effectiveness of pyoimmunogen in the immunization of volunteer donors].
    Krokhina MA; Grishina IA; Arkhipova NA; Zarubina EK; Edvabnaia LS
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):95-8. PubMed ID: 7331614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of an immunoenzyme method for detecting specific antibodies to Pseudomonas aeruginosa in patients with acute and chronic lung diseases].
    Dubeĭkovskaia ZA; Savitskaia KI; Antsiferova NG; Shakhanina KL; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):53-7. PubMed ID: 6415971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoenzyme method of diagnosing suppurative-septic complications due to Pseudomonas aeruginosa and Proteus].
    Bulava GV; Ermolin GA; Grigor'ev NI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):89-93. PubMed ID: 6431720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Derivation and experimental evaluation of polyvalent corpuscular vaccine for prevention of infections caused by Pseudomonas aeruginosa. I. Development of polyvalent corpuscular vaccine].
    Moroz AF; Radkevich SA; Antsiferova NG; Brodinova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):44-9. PubMed ID: 6171956
    [No Abstract]   [Full Text] [Related]  

  • 28. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possible diagnosis of Pseudomonas aeruginosa infection by an immunoenzyme method using pyoimmunogen as the antigen].
    Severtsova MK; Dubova VG; Getmanova MA; Temper RM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):63-6. PubMed ID: 3137744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Donor plasma with anti-Pseudomonas aeruginosa activity as a directed-action preparation].
    Nazarchuk LV
    Vrach Delo; 1987 Jul; (7):96-8. PubMed ID: 3114958
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
    Minukhin VV; Tsyganenko VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled trials of a polyvalent pseudomonas vaccine in burns.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1979 Nov; 2(8150):977-82. PubMed ID: 91774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serologic diagnosis of intestinal yersiniosis. The design of a stable erythrocyte preparation for the indirect hemagglutination reaction].
    Koroliuk AM; Golovacheva SN; Dulatova MV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):30-4. PubMed ID: 2741602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Natural antibodies against Pseudomonas aeruginosa in human gamma globulin preparations].
    Chekan LV; Min'ovich FL; Kutimova LR; Edvabnaia LS; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):85-9. PubMed ID: 6170196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibody titer of the serum of patients with Pseudomonas aeruginosa infection. Passive hemagglutination test using original endotoxin protein(OEP)].
    Saku K
    Kansenshogaku Zasshi; 1975 Sep; 49(9):358-63. PubMed ID: 814177
    [No Abstract]   [Full Text] [Related]  

  • 36. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The diagnostic value of a meningococcal-B erythrocyte diagnostic agent based on the group-specific polysaccharide].
    Martynov IuV; Demina AA; Alliluev AP; Kotel'nikova OV; Kuvakina VI; Marinin IIu; Korneeva SA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):63-9. PubMed ID: 2129075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation of mouse monoclonal antibodies produced by immunisation with a single serotype component of a polyvalent Pseudomonas aeruginosa vaccine.
    Barclay GR; Yap PL; McClelland DB; Jones RJ; Roe EA; McCann MC; Micklem LR; James K
    J Med Microbiol; 1986 Feb; 21(1):87-90. PubMed ID: 3081727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of experimental burn wound sepsis by postburn immunization with polyvalent Pseudomonas antigen.
    Nance FC; Hines JL; Fulton RE; Bornside GH
    Surgery; 1970 Jul; 68(1):248-53. PubMed ID: 10483476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.